Akero Therapeutics, Inc. Share Price
AKROAkero Therapeutics, Inc. Stock Performance
Open $54.22 | Prev. Close $54.29 | Circuit Range N/A |
Day Range $54.22 - $54.34 | Year Range $21.39 - $58.33 | Volume 82,529 |
Average Traded $54.30 |
Akero Therapeutics, Inc. Share Price Chart
About Akero Therapeutics, Inc.
Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Akero Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $54.22 | $54.30 | +0.00% |
12-Nov-25 | $54.22 | $54.30 | +0.11% |
11-Nov-25 | $54.10 | $54.24 | +0.17% |
10-Nov-25 | $54.02 | $54.15 | +0.20% |
07-Nov-25 | $53.99 | $54.04 | +0.20% |
06-Nov-25 | $54.06 | $53.93 | -0.20% |
05-Nov-25 | $54.02 | $54.04 | +0.00% |
FAQs on Akero Therapeutics, Inc. Share Price
Can I buy Akero Therapeutics, Inc. shares in India?
What is the share price of Akero Therapeutics, Inc.?
What is the 5 year returns of Akero Therapeutics, Inc.?
What are the high & low stock price of Akero Therapeutics, Inc. today?
What is the 52-week high and low of Akero Therapeutics, Inc. stock?